Stephens Investment Management Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$81.1M Buy
1,204,553
+130,088
+12% +$8.67M 0.87% 45
2026
Q1
$67.5M Buy
1,074,465
+31,664
+3% +$2.21M 0.92% 34
2025
Q4
$69.2M Buy
1,042,801
+181,701
+21% +$11.7M 0.9% 41
2025
Q3
$57.9M Sell
861,100
-16,732
-2% -$1.32M 0.75% 54
2025
Q2
$76.6M Buy
877,832
+36,748
+4% +$2.88M 1.01% 39
2025
Q1
$57.4M Buy
841,084
+137,165
+19% +$11.2M 0.83% 42
2024
Q4
$54.7M Buy
703,919
+19,434
+3% +$1.44M 0.73% 56
2024
Q3
$45.9M Buy
684,485
+19,279
+3% +$1.58M 0.63% 69
2024
Q2
$75.4M Buy
665,206
+35,625
+6% +$4.5M 1.06% 31
2024
Q1
$87.3M Buy
629,581
+3,647
+0.6% +$458K 1.16% 26
2023
Q4
$77.7M Sell
625,934
-4,713
-0.7% -$481K 1.14% 26
2023
Q3
$58.8M Buy
630,647
+7,918
+1% +$893K 0.97% 35
2023
Q2
$80M Buy
622,729
+8,806
+1% +$1.07M 1.25% 14
2023
Q1
$71.3M Buy
613,923
+661
+0.1% +$74K 1.19% 18
2022
Q4
$68.7M Buy
613,262
+1,457
+0.2% +$160K 1.25% 12
2022
Q3
$49.3M Buy
611,805
+35,592
+6% +$3.01M 0.93% 37
2022
Q2
$42.9M Sell
576,213
-1,567
-0.3% -$143K 0.79% 53
2022
Q1
$73.9M Buy
577,780
+10,916
+2% +$1.19M 1.08% 25
2021
Q4
$76.1M Sell
566,864
-124,448
-18% -$17.9M 0.98% 30
2021
Q3
$94.5M Sell
691,312
-22,884
-3% -$2.89M 1.29% 12
2021
Q2
$76.2M Sell
714,196
-5,792
-0.8% -$556K 1.04% 23
2021
Q1
$64.7M Buy
719,988
+13,068
+2% +$1.23M 0.94% 40
2020
Q4
$65.3M Sell
706,920
-64,040
-8% -$5.72M 0.97% 36
2020
Q3
$79.5M Sell
770,960
-96,204
-11% -$10.1M 1.41% 8
2020
Q2
$87.9M Sell
867,164
-195,964
-18% -$17.5M 1.59% 5
2020
Q1
$71.6M Sell
1,063,128
-71,468
-6% -$4.45M 1.73% 3
2019
Q4
$62M Sell
1,134,596
-58,728
-5% -$2.79M 1.17% 20
2019
Q3
$44.5M Buy
1,193,324
+31,908
+3% +$1.24M 0.89% 48
2019
Q2
$43.5M Buy
1,161,416
+60,028
+5% +$1.89M 0.82% 48
2019
Q1
$32.8M Sell
1,101,388
-60,088
-5% -$2.11M 0.67% 73
2018
Q4
$34.8M Sell
1,161,476
-67,828
-6% -$2.15M 0.83% 48
2018
Q3
$44M Sell
1,229,304
-51,936
-4% -$1.61M 0.81% 52
2018
Q2
$30.2M Buy
1,281,240
+11,400
+0.9% +$242K 0.61% 77
2018
Q1
$23.5M Buy
1,269,840
+191,796
+18% +$2.84M 0.51% 86
2017
Q4
$15.5M Buy
1,078,044
+308,748
+40% +$4.01M 0.35% 104
2017
Q3
$9.41M Buy
769,296
+618,384
+410% +$10.9M 0.22% 132
2017
Q2
$2.76M Hold
150,912
0.07% 157
2017
Q1
$3.2M Sell
150,912
-9,084
-6% -$177K 0.08% 155
2016
Q4
$2.39M Buy
159,996
+87,528
+121% +$1.55M 0.07% 152
2016
Q3
$1.59M Sell
72,468
-266,816
-79% -$5.94M 0.05% 160
2016
Q2
$6.73M Buy
339,284
+24
+0% +$409 0.22% 139
2016
Q1
$5.76M Buy
339,260
+4,580
+1% +$76.5K 0.2% 133
2015
Q4
$6.85M Sell
334,680
-7,600
-2% -$158K 0.24% 135
2015
Q3
$7.35M Sell
342,280
-48,180
-12% -$1.07M 0.26% 133
2015
Q2
$7.81M Buy
390,460
+113,180
+41% +$1.99M 0.23% 136
2015
Q1
$4.32M Buy
+277,280
New +$4.19M 0.13% 142

Other funds holding DXCM

Stephens Investment Management Group's DXCM Position: Q2 2026 in Review

Stephens Investment Management Group increased its DexCom (DXCM) stake by 12% in Q2 2026, buying an estimated $8.67M and bringing the position to 1,204,553 shares worth $81.1M. The position accounts for 0.87% of the portfolio, ranked #45.

Stephens Investment Management Group first reported a position in DXCM in Q1 2015 and has held it in 46 quarters since. The position peaked at $94.5M in Q3 2021. 496 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Stephens Investment Management Group held 1,204,553 shares of DexCom worth $81.1M as of Q2 2026.
  • Stephens Investment Management Group bought 130,088 DexCom shares in Q2 2026, an estimated $8.67M.
  • DexCom made up 0.87% of Stephens Investment Management Group's portfolio in Q2 2026, its #45 holding.
  • Stephens Investment Management Group first reported a position in DexCom in Q1 2015 and has held it in 46 quarters since.
  • Stephens Investment Management Group's DexCom position peaked at $94.5M in Q3 2021.
  • 496 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Stephens Investment Management Group's 13F filing for Q2 2026, filed 29 Jul 2026.